Table 4.
Multivariate Regression: Rheumatoid Arthritis vs. Osteoarthritis (Reference) | ||||
---|---|---|---|---|
Effect | Adjusted Odds Ratio | 95% Confidence Limit | P-Value | |
Cumulative Adverse events | 0.98 | 0.92 | 1.05 | 0.63 |
Mechanical Ventilation | 0.91 | 0.70 | 1.19 | 0.49 |
Blood Product Transfusion | 1.51 | 1.44 | 1.59 | <0.001 |
Prolonged Hospitalization | 1.10 | 1.05 | 1.15 | <0.001 |
Increased Cost of Hospitalization | 1.16 | 1.11 | 1.21 | <0.001 |
Reference = 1 (Osteoarthritis). Cumulative adverse event occurrence is defined by occurrence of any of the following: pulmonary embolism, deep venous thrombosis, cerebrovascular event, pulmonary compromise, sepsis, cardiac adverse events including myocardial infarction, pneumonia, all other infections, acute renal failure, gastrointestinal adverse events and in-hospital mortality